RecruitingPhase 3NCT06502990
Open-label Study to Evaluate Metreleptin in Children Under 6 Years of Age With Generalised Lipodystrophy
Studying Acquired generalized lipodystrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Amryt Pharma
- Intervention
- Metreleptin(drug)
- Enrollment
- 15 enrolled
- Eligibility
- 5 years · All sexes
- Timeline
- 2025 – 2026
Study locations (12)
- UZ Leuven, Leuven, Belgium
- Hôpital Necker - Enfants Malades, Paris, France
- Assistance Publique-Hopitaux de Paris (AP-HP) - Hopital Universitaire Robert-Debre, Paris, France
- Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany
- Universitaetsklinikum Ulm - Klinik fuer Kinder- und Jugendmedizin, Ulm, Germany
- IRCCS Ospedale Pediatrico Bambino Gesù, Chieti, Italy
- Azienda Ospedaliera Universitaria "Federico II", Naples, Italy
- Azienda Ospedaliero Universitaria Maggiore della Carità di Novara, Novara, Italy
- Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
- Azienda Ospedaliero Universitaria Pisana, Pisa, Italy
- IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy
- Ospedale Filippo Del Ponte Varese - ASST Sette Laghi, Varese, Italy
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06502990 on ClinicalTrials.govOther trials for Acquired generalized lipodystrophy
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07220785Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized LipodystrophyRegeneron Pharmaceuticals
- ACTIVE NOT RECRUITINGPHASE3NCT06548100A Study of the Safety of Mibavademab in Pediatric and Adult Participants Switching From Metreleptin to Mibavademab for the Treatment of Generalized Lipodystrophy (GLD)Regeneron Pharmaceuticals
- ACTIVE NOT RECRUITINGNANCT03936829Cyclophosphamide in the Treatment of Associated Acquired Lipodystrophy Syndrome With Type 1 DiabetesChildren's Hospital of Fudan University
- RECRUITINGNCT03553420Registry for Patients With LipodystrophyUniversity of Ulm
- ACTIVE NOT RECRUITINGPHASE3NCT02262832Compassionate Use of Metreleptin in Previously Treated People With Generalized LipodystrophyNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)